Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses

Pharmaceutical Cost Trends: A Decade of Change

__timestampPharming Group N.V.Supernus Pharmaceuticals, Inc.
Wednesday, January 1, 201441672745758000
Thursday, January 1, 201552478518423000
Friday, January 1, 2016492511811986000
Sunday, January 1, 20171493029715215000
Monday, January 1, 20182537176815356000
Tuesday, January 1, 20192392127416660000
Wednesday, January 1, 20202533823652459000
Friday, January 1, 20212018296675061000
Saturday, January 1, 20221756200087221000
Sunday, January 1, 20232521200083779000
Loading chart...

Unveiling the hidden dimensions of data

Cost Insights: A Comparative Analysis of Pharming Group N.V. and Supernus Pharmaceuticals, Inc.

In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for strategic planning and competitive advantage. This analysis delves into the cost of revenue trends for Pharming Group N.V. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Pharming Group N.V. saw a steady increase in costs, peaking in 2018 with a 510% rise from 2014. Meanwhile, Supernus Pharmaceuticals, Inc. experienced a dramatic surge, with costs escalating by over 1,400% by 2022. Notably, 2020 marked a pivotal year for Supernus, with costs more than tripling compared to the previous year. These insights highlight the dynamic nature of cost management in the pharmaceutical sector, emphasizing the need for companies to adapt to market demands and operational challenges.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025